Immunization

A regulatory protein that weakens the immune response to viral RNA presents a new treatment target for cancer.

Targeting the immune response to cancer may lead to new immunotherapies.

Scientists continue to pursue the development of an HIV cure.

Since November 2015, approximately 25% of adults who receive annual seasonal influenza vaccination are immunized in pharmacies or retail health care settings.

A bad influenza season might call for higher-dose flu vaccines in older adults.

The number of outbreaks of pertussis across the country has been growing.

Annual vaccination against seasonal influenza is recommended for all persons aged ≥6 months.

In our quest to identify the areas and activities that show the greatest positive impact and value in care and outcomes, we must aim to not let good science and evidence get away from us, particularly when considering vaccination.

Pharmacists’ accessibility and interactions with the public may help increase HPV vaccine coverage.

The CDC has released its final 2017 updated adult vaccination recommendations approved by the Advisory Committee on Immunization Practices (ACIP).

Few health care innovations compare to vaccines in terms of reduced morbidity and mortality

Top news of the day from across the health care landscape.

Streptococcus pneumonia is an indiscriminate killer.

A new CDC report assesses factors that influence pregnant women’s adherence to vaccination coverage recommendations.

A personalized vaccine may effectively treat HER2-postive breast cancer.

Top news of the day from across the health care landscape.

HPV infection is preventable with immunization, but even though the HPV vaccine has been available for 10 years, uptake is far lower than acceptable.

Vaccines are extremely topical, with questions routinely being asked, particularly during the winter season.

Other highly ranked services included alcohol screening, aspirin therapy for cardiovascular disease prevention, and colorectal cancer screening.

Researchers from Australia set out to determine health consumers' information needs and concerns related to childhood vaccination.

The FDA recently approved an Investigational New Drug application submitted by Valneva SE.

Controversial clinical research may gain significant traffic, but may not always be based on facts.

Screening tools are needed so that health care professionals can offer immunizations at every convenient opportunity.

Persistent vaccine-induced immunity through the typical cold weather, high risk period, and into the subsequent seasons is important in areas with year-round influenza activity.

Healthy People 2020, the national health promotion and disease intervention initiative, set the goal influenza vaccination rate in the community at 70%. Despite this goal, reports show that vaccination rates are way under expectations at 44%.